Semaglutide, a drug used for diabetes and weight loss, might help reduce opioid overdoses in people with OUD and T2D.

Semaglutide, sold as Wegovy and Ozempic, may reduce opioid overdoses in people with opioid-use disorder and type 2 diabetes.

People using semaglutide, a common drug for diabetes and weight loss, may experience ... of a minor risk, given their limited data. Their investigation is still in progress. Link between eating ...

Researchers from the University of Liverpool have found that the weight-loss drug tirzepatide could significantly reduce the ...

A trial found that patients who took it alongside diet and exercise typically lost a fifth of their body weight in 36 weeks.

Since being deemed a public health emergency in 2017, opioids are responsible for 72% of drug overdose deaths in the United ...

semaglutide may promote weight loss and decrease the risk of cancer, diabetes and cardiovascular disease in individuals with obesity or overweight. “Ozempic is a safe medication with a variety ...

has not only proven effective in treating weight loss and diabetes: Mounting evidence suggests these drugs may be effective at treating other conditions like cancer, Alzheimer’s and COVID-19.

The trials tested the weight-loss drug in obese people with or without Type 2 diabetes ... ago Falls linked to increased risk of dementia in older people Cognitive decline may increase an older ...

The weight-loss drug liraglutide helped ... belly fat Obesity increases risk of severe infection, especially in diabetes patients Wegovy, Ozempic may someday be available as monthly injection ...

SO THE LINK BETWEEN A POPULAR WEIGHT LOSS DRUG AND SUICIDAL THOUGHTS, THERE’S A NEW STUDY THAT’S NOW SUGGESTING THAT THAT RISK INCREASES ... type 2 diabetes, and down the road they may develop ...

Researchers have identified a potential new approach to address the opioid overdose epidemic. Semaglutide was shown to lower opioid overdoses in people with opioid-use disorder and type 2 diabetes.